Table 3. Subject demographics and rejected trials and subjects in the analyses comparing PD patients on and off medication.
Subject Group | On-Med | Off-Med | |
---|---|---|---|
Tested subjects | 22 | 22 | |
Button Press | Rejected trials due to BP | 1392 (29.5%) | 1195 (30.5%) |
Rejected subjects | 2 (9.1%) | 2 (9.1%) | |
Remaining subjects after rejection due to BP | 20 | 20 | |
Eye movement | Rejected trials due to eye movement | 1228 (26.1%) | 936 (23.9%) |
Rejected subjects | 0 | 1 (4.6%) | |
Effect of both | Rejected trials in total | 1744 (37.0%) | 1405 (35.8%) |
Rejected subjects | 1 (4.6%) | 0 | |
Remaining subjects after rejection due to eye movement | 19 | 19 | |
Imbalance | Rejected subjects | 3 (13.6%) | 2 (9.1%) |
Total | Rejected subjects in total | 6 (27.3%) | 5 (22.7%) |
Remaining subjects | 16 | 17 | |
Final rejected subjects | 7 (31.8%) | ||
Final subjects | 15 | ||
Age (±SD) of final subjects | 70.0 (6.2 SD) | ||
MDS-UPDRS (±SD) of final subjects | 13.9 (8.4 SD) | 21.8 (11.4 SD) |